N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer

Overview of attention for article published in Cell & Bioscience, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,882 followers.

🔬 New research indicates that N6-methyladenosine-mediated CELF2 promotes alternative splicing of CD44, affecting the endoplasmic reticulum-associated degradation pathway and regulating the biological behavior of #PancreaticCancer cells. 🔓 https://t.co/1Jc

15 Aug 2022

Reply Repost Favourite

New article: N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer https://t.co/ZNZCvf9Ic2 #pancreaticcancer #oncology https://t.co/mWrrqI322z

09 Aug 2022

Reply Repost Favourite

N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer https://t.co/dUXbSH37AN

08 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.